Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2020-03-25FDA Approved: VERAPAMIL HYDROCHLORIDE — Original Application (Caplin Steriles Limited)
FDA approves Caplin Steriles Limited's Verapamil Hydrochloride under an Original Application (ANDA). This confirms the availability of a gen…
-
CLINICAL_TRIALS research · 2020-03-20Clinical Trial Update: Implementing Evidence Based Treatment of Hypertension [NA]
Clinical trial update reporting completion and posted results for a hypertension study focused on evidence-based treatment approaches.
-
FDA approval · 2020-03-16FDA Approved: AMLODIPINE, VALSARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for a generic fixed-dose combination of amlodipine, valsartan, and hydrochlorothiazide manufactured …
-
FDA approval · 2020-03-16FDA Approved: AMLODIPINE, VALSARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin's supplemental application for a generic fixed-dose combination of amlodipine, valsartan, and hydrochlorothiazide for the…
-
FDA approval · 2020-03-13FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (Jubilant Cadista Pharmaceuticals Inc.)
FDA approved Jubilant Cadista Pharmaceuticals' supplemental application for Losartan Potassium and Hydrochlorothiazide, a generic combinatio…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-03-13Clinical Trial Update: Nutraceutical Supplement in the Management of Hypertension [Phase 1, Phase 2]
Phase 1/2 trial update for a nutraceutical supplement being studied for hypertension management.
-
FDA approval · 2020-03-11FDA Approved: CARVEDILOL — Supplemental Application (Advagen Pharma Ltd)
FDA approved a supplemental application for carvedilol (Advagen Pharma Ltd) under an ANDA, authorizing a supplemental approval for this gene…
-
CLINICAL_TRIALS trial_result · 2020-03-11Clinical Trial Update: Effects and Safety of Menthol on Blood Pressure and Metabolic Parameters in Prehypertensive and Mild Hypertensive Patients [Phase 2, Phase 3]
Phase 2/3 trial assessing the effects and safety of menthol on blood pressure and metabolic parameters in individuals with prehypertension o…
-
CLINICAL_TRIALS trial_result · 2020-03-10Clinical Trial Update: The Effect of Nebivolol in Hypertensive Patients With Coronary Arterial Spasm [Phase 4]
Phase 4 trial update on nebivolol in hypertensive patients with coronary vasospasm has completed.
-
FDA approval · 2020-03-09FDA Approved: EDARBYCLOR — Supplemental Application (Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals))
The FDA approved a supplemental application for EDARBYCLOR, a fixed-dose combination of azilsartan medoxomil and chlorthalidone, manufacture…
-
FDA approval · 2020-03-06FDA Approved: EDARBI — Supplemental Application (Azurity Pharmaceuticals, Inc.)
FDA approved a supplemental application for EDARBI (azilsartan medoxomil) submitted by Azurity Pharmaceuticals, Inc.
-
FDA approval · 2020-03-04FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for the fixed-dose combination of losartan potassium and hydrochlorothiazide by Teva Pharmaceuti…
-
FDA approval · 2020-03-03FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (NorthStar Rx LLC)
FDA approved a supplemental application for the generic combination product Losartan Potassium and Hydrochlorothiazide, marketed by NorthSta…
-
FDA approval · 2020-03-03FDA Approved: CAPTOPRIL — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved a supplemental application for CAPTOPRIL by Camber Pharmaceuticals, granting approval of an additional generic captopril produc…
-
FDA approval · 2020-03-03FDA Approved: CAPTOPRIL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for CAPTOPRIL (captopril) from Hikma Pharmaceuticals USA Inc. under an ANDA. The action concerns…
-
FDA approval · 2020-03-03FDA Approved: CARVEDILOL — Supplemental Application (Quallent Pharmaceuticals Health LLC)
FDA approves a supplemental application for carvedilol from Quallent Pharmaceuticals Health LLC, approving an updated generic product.
-
FDA approval · 2020-03-02FDA Approved: CARVEDILOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for carvedilol from Teva Pharmaceuticals USA, resulting in updated labeling. The approval confirms c…
-
CLINICAL_TRIALS trial_result · 2020-02-26Clinical Trial Update: Center of Research Translation (CORT) Project 2 [Phase 2, Phase 3]
Phase 2/3 clinical trial update from the Center of Research Translation (CORT) Project 2 has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-02-26Clinical Trial Update: The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose [Phase 4]
Phase 4 trial update on the blood pressure and metabolic effects of nebivolol in hypertensive patients with impaired glucose tolerance or im…
-
FDA approval · 2020-02-24FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (Alembic Pharmaceuticals Limited)
The FDA approved a supplemental application for a generic fixed-dose combination of losartan potassium and hydrochlorothiazide, manufactured…
-
FDA approval · 2020-02-21FDA Approved: AMLODIPINE AND BENAZEPRIL HYDROCHLORIDE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
The FDA approved a supplemental application for amlodipine and benazepril hydrochloride from Heritage Pharmaceuticals (d/b/a Avet) to market…
-
FDA approval · 2020-02-21FDA Approved: AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for a generic fixed-dose combination tablet containing amlodipine besylate …
-
FDA approval · 2020-02-21FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
The FDA approved a supplemental application for LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE from Unichem Pharmaceuticals (USA), Inc., maintai…
-
FDA approval · 2020-02-21FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
The FDA approved a supplemental application for Losartan Potassium and Hydrochlorothiazide from Macleods Pharmaceuticals Limited under an AN…
-
FDA approval · 2020-02-21FDA Approved: AMLODIPINE AND BENAZEPRIL HYDROCHLORIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for a generic amlodipine and benazepril hydrochloride product from Rising Pharma Holdings, expanding…